Latest Articles
Organon Provides Update on Phase 2 ELENA Proof-of-Concept Study Evaluating OG-6219 in Patients with Endometriosis-Related Pain - BioSpace
Organon Provides Update on Phase 2 ELENA Proof-of-Concept Study Evaluating OG-6219 in Patients with Endometriosis-Related Pain BioSpace
Published: July 3, 2025, 6:02 a.m.
Minimally Invasive Surgery With Sentinel Lymph Node Mapping in Elderly Patients With Early-Stage Endometrial Cancer: A Subgroup Analysis of a Prospective Cohort Study - Cureus
Minimally Invasive Surgery With Sentinel Lymph Node Mapping in Elderly Patients With Early-Stage Endometrial Cancer: A Subgroup Analysis of a Prospective Cohort Study Cureus
Published: July 3, 2025, 5:42 a.m.
Lena Dunham reveals she's 'in the process of expanding our family' with her husband after endometriosis battle and a hysterectomy - Nine - Honey
Lena Dunham reveals she's 'in the process of expanding our family' with her husband after endometriosis battle and a hysterectomy Nine - Honey
Published: July 2, 2025, 10:23 p.m.
Organon Discontinues Endometriosis Drug Development After Failed Phase 2 Trial - Femtech Insider
Organon Discontinues Endometriosis Drug Development After Failed Phase 2 Trial Femtech Insider
Published: July 2, 2025, 9:17 p.m.
Organon to halt development of endometriosis pain drug after mid-stage trial failure - whbl.com
Organon to halt development of endometriosis pain drug after mid-stage trial failure whbl.com
Published: July 2, 2025, 9:02 p.m.
Organon Stops Work on Endometriosis Drug After Failure in Phase 2 Test - MedCity News
Organon Stops Work on Endometriosis Drug After Failure in Phase 2 Test MedCity News
Published: July 2, 2025, 8:17 p.m.
Organon’s endometriosis drug discontinued after failing to improve pain - PharmaLive
Organon’s endometriosis drug discontinued after failing to improve pain PharmaLive
Published: July 2, 2025, 6:39 p.m.
Organon Drops Drug Development For Endometriosis Pain After Mid-Stage Study Fails To Show Results By Stocktwits - Investing.com India
Organon Drops Drug Development For Endometriosis Pain After Mid-Stage Study Fails To Show Results By Stocktwits Investing.com India
Published: July 2, 2025, 5:15 p.m.
AstraZeneca’s New Study on Durvalumab and Olaparib in Endometrial Cancer: Market Implications - TipRanks
AstraZeneca’s New Study on Durvalumab and Olaparib in Endometrial Cancer: Market Implications TipRanks
Published: July 2, 2025, 5:03 p.m.
Organon Drops Drug Development For Endometriosis Pain After Mid-Stage Study Fails To Show Results - Stocktwits
Organon Drops Drug Development For Endometriosis Pain After Mid-Stage Study Fails To Show Results Stocktwits
Published: July 2, 2025, 4:43 p.m.
Link copied to clipboard!